Effects of Renin—Angiotensin System Inhibition on Cardiac Hypertrophy and Fibrosis in Spontaneously Hypertensive Rats
The present study examined whether the inhibition of the renin-angiotensin system can change the cardiac remodeling process in spontaneously hypertensive rats (SHR). First, we administered AT1, blockade (losartan), AT2 blockade (PD123319), or ACE inhibitor (enalapril) to SHR from 10 to 20 weeks of age. Both losartan and enalapril reduced the arterial systolic blood pressure (BP) as well as the collagen concentration compared with the untreated SHR (U-SHR) to the level of Wistar Kyoto rats (WKY). Both agents also reduced both the left ventricular (LV) weight and the ratio of LV to body weight (BW) compared with the untreated SHR, although these measures were still larger than those of WKY. However, PD123319 was without effect. Second, to inhibit the plasma angiotensinogen (ATN) in SHR, we intravenously injected antisense oligodeoxynucleotides (ODNs) against rat ATN coupled to asialoglyco-protein carrier molecules into SHR (A-SHR) from 10 to 20 weeks via their tail veins twice a week. Both the ATN and Ang II concentrations in plasma decreased in A-SHR compared with those of the sense-treated SHR (S-SHR) or U-SHR. The BP in A-SHR was reduced in comparison with those of S-SHR or U-SHR, although BP in A-SHR was still higher than that in WKY. Both LV weight and the ratio of LV to BW also decreased in A-SHR compared with S-SHR or U-SHR. No difference in the LV collagen concentrations was observed among all SHR groups. These findings showed that ATN inhibition, ACE, and AT1 blockade could reduce the hypertrophy of myocytes in SHR. However, since the partial BP reduction did not produce changes in the remodeling of matrix tissue, it may be that both the reduction of BP and the inhibition of RAS play a crucial role in cardiac hypertrophy in SHR.
KeywordsCardiac Hypertrophy Angiotensin Converting Enzyme Activity Antisense ODNs Plasma Angiotensin Converting Enzyme Left Ventricular Weight
Unable to display preview. Download preview PDF.
- 6.Schunkert H, Sadoshima J, Cornelius T, Kagaya Y, Weinberg EO, Izumo S, Riegger G, Lorell BH. 1995. Angiotensin II-induced growth responses in isolated adult rat hearts: evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 76:489–497.PubMedCrossRefGoogle Scholar
- 25.Kojima M, Shiojima I, Yamazaki T, Komuro I, Yunzeng Z, Ying W, Mizuni T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. 1994. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocytes hypertrophy in vitro. Circulation 89:2204–2211.PubMedCrossRefGoogle Scholar
- 26.Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. 1995. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92:10663–10667.PubMedCrossRefGoogle Scholar